Drug Ther Bull. 2017 Oct;55(10):117-120. doi: 10.1136/dtb.2017.10.0541.
Proton pump inhibitors (PPIs) are widely prescribed and many people remain on them for years. In some, there may be good justification for long-term use; for example, in those with oesophageal stricture, Barrett's oesophagus or a history of a bleeding gastrointestinal ulcer, or to provide gastroprotection in those at high risk of gastrointestinal complications from taking NSAIDs. However, PPIs are often not used in line with clinical guidelines. In addition, there are concerns that many people take them for long periods to manage less serious conditions (e.g. indigestion) and may prefer taking them to addressing factors such as diet, obesity or alcohol that may be contributing to their symptoms. Although PPIs are well-tolerated, there is increasing evidence that they may be associated with a range of long-term adverse effects. Here, we review the safety of PPIs and consider whether long-term prescribing needs to be reassessed.
质子泵抑制剂(PPIs)被广泛处方,许多人会持续服用数年。对一些人来说,长期使用可能有充分的理由;例如,患有食管狭窄、巴雷特食管或有胃肠道溃疡出血史的患者,或者用于为服用非甾体抗炎药而有高胃肠道并发症风险的患者提供胃保护。然而,质子泵抑制剂的使用常常不符合临床指南。此外,有人担心许多人长期服用它们来治疗不太严重的病症(如消化不良),并且可能更愿意服用它们而不是解决可能导致其症状的饮食、肥胖或饮酒等因素。尽管质子泵抑制剂耐受性良好,但越来越多的证据表明它们可能与一系列长期不良反应有关。在此,我们回顾质子泵抑制剂的安全性,并考虑是否需要重新评估长期处方。